Summit Therapeutics (SMMT) Interest Coverage Ratio (QoQ) (2017 - 2024)
Summit Therapeutics (SMMT) Interest Coverage Ratio (QoQ) (2017 - 2024) Analysis & Trends
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Summit Therapeutics | 11.62 Bn | 11.03 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 62.23% |
| Sep 30, 2024 | -23.73% |
| Jun 30, 2024 | -41.50% |
| Mar 31, 2024 | -10.24% |
| Dec 31, 2023 | -75.38% |
| Sep 30, 2023 | -55.14% |
| Jun 30, 2023 | 92.98% |
| Sep 30, 2022 | -25.95% |
| Jun 30, 2022 | 73.95% |
| Mar 31, 2022 | -100.57% |
| Jun 30, 2021 | 82.47% |
| Mar 31, 2021 | -1,283.08% |
| Dec 31, 2020 | -916.51% |
| Oct 31, 2019 | -14.48% |
| Oct 31, 2018 | -766.77% |
| Jul 31, 2018 | 154.11% |
| Apr 30, 2018 | -108.80% |
| Jan 31, 2018 | 24.34% |
| Oct 31, 2017 | -5.75% |
| Jul 31, 2017 | -4.08% |